Hypomagnesemia in type 2 diabetic nephropathy: A novel predictor of end-stage renal disease

Diabetes Care

Volumn 35, Issue 7, 2012, Pages 1591-1597

  Sakaguchi, Yusuke ^a   Shoji, Tatsuya ^a   Hayashi, Terumasa ^a   Suzuki, Akira ^a   Shimizu, Morihiro ^a   Mitsumoto, Kensuke ^a   Kawabata, Hiroaki ^a   Niihata, Kakuya ^a   Okada, Noriyuki ^a   Isaka, Yoshitaka ^b   Rakugi, Hiromi ^b   Tsubakihara, Yoshiharu ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM; CREATININE; HEMOGLOBIN A1C; MAGNESIUM; PHOSPHORUS;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; HYPOMAGNESEMIA; LABORATORY TEST; LOW RISK POPULATION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PREDICTION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84862866376     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0226     Document Type: Article

References (36)

1. Laurant P, Berthelot A. Influence of endothelium on Mg2+-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat. Eur J Pharmacol 1994;258:167-172 (Pubitemid 24179977)
2. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007;458:48-56 (Pubitemid 46201802)
3. Wolf FI, Trapani V, Simonacci M, FerréS, Maier JA. Magnesium deficiency and endothelial dysfunction: is oxidative stress involved? Magnes Res 2008;21:58-64 (Pubitemid 351588095)
4. Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH, Szklo M. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 1999;9:159-165 (Pubitemid 29144455)
5. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998;136:480-490 (Pubitemid 28413547)
6. Ohira T, Peacock JM, Iso H, Chambless LE, Rosamond WD, Folsom AR. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2009;169:1437-1444
7. Rude RK. Magnesium deficiency and diabetes mellitus. Causes and effects. Postgrad Med 1992;92:217-219, 222-224
8. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26:1147-1152 (Pubitemid 36929263)
9. Migdalis IN, Xenos K, Chairopoulos K, Varvarigos N, Leontiades E, Karmaniolas K. Ca(2+)-Mg(2+)-ATPase activity and ionized calcium in Type 2 diabetic patients with neuropathy. Diabetes Res Clin Pract 2000;49:113-118 (Pubitemid 30665456)
10. de Valk HW, Hardus PL, van Rijn HJ, Erkelens DW. Plasma magnesium concentration and progression of retinopathy. Diabetes Care 1999;22:864-865 (Pubitemid 29220804)
11. Rodríguez-Morán M, Guerrero-Romero F. Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes. Arch Med Res 2001;32:300-303 (Pubitemid 32618658)
12. Corsonello A, Ientile R, Buemi M, et al. Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria. Am J Nephrol 2000;20:187-192 (Pubitemid 30445312)
13. Pham PC, Pham PM, Pham PA, et al. Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol 2005;63:429-436
14. Pham PC, Pham PM, Pham PT, Pham SV, Pham PA, Pham PT. The link between lower serum magnesium and kidney function in patients with diabetes mellitus Type 2 deserves a closer look. Clin Nephrol 2009;71:375-379
15. Matsuo S, Imai E, Horio M, et al.; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-992
16. Elin RJ. Assessment of magnesium status. Clin Chem 1987;33:1965-1970
17. Seino Y, Nanjo K, Tajima N, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 2010;53:450-467 [in Japanese]
18. Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. BMJ 1973;4:643-646
19. Teramoto T, Sasaki J, Ueshima H, et al.; Japan Atherosclerosis Society (JAS) Committee for Epidemiology and Clinical Management of Atherosclerosis. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007;14:155-158
20. Dewitte K, Dhondt A, Giri M, et al. Differences in serum ionized and total magnesium values during chronic renal failure between nondiabetic and diabetic patients: a cross-sectional study. Diabetes Care 2004;27:2503-2505 (Pubitemid 39281412)
21. Kroll MH, Elin RJ. Relationships between magnesium and protein concentrations in serum. Clin Chem 1985;31:244-246 (Pubitemid 16209722)
22. Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 2011;34:2116-2122
23. Matsuzaki H, Ohdachi J, Fuchigami M, et al. Changes in N-acetyl-beta-D-glucosaminidase activity in the urine and urinary albumin excretion in magnesium deficient rats. Biosci Biotechnol Biochem 2002;66:192-194 (Pubitemid 39251110)
24. de Araujo M, Andrade L, Coimbra TM, Rodrigues AC Jr, Seguro AC. Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure. J Am Soc Nephrol 2005;16:3339-3349 (Pubitemid 46179337)
25. Grafton G, Bunce CM, Sheppard MC, Brown G, Baxter MA. Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes 1992;41:35-39
26. Guerrero-Romero F, Rodríguez-Morán M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39:209-213 (Pubitemid 35470535)
27. Zofková I, Kancheva RL. The relationship between magnesium and calciotropic hormones. Magnes Res 1995;8:77-84
28. Fatemi S, Ryzen E, Flores J, Endres DB, Rude RK. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. J Clin Endocrinol Metab 1991;73:1067-1072 (Pubitemid 21901148)
29. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev 2003;24:47-66
30. 2+ uptake in mouse distal convoluted tubule cells. Kidney Int 1997;51:1710-1718
31. Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 2006;1:825-831
32. Mandon B, Siga E, Chabardes D, Firsov D, Roinel N, De Rouffignac C. Insulin stimulates Na+, Cl-, Ca2+, and Mg2+ transports in TAL ofmouse nephron: cross-potentiation with AVP. Am J Physiol 1993;265:F361-F369 (Pubitemid 23296534)
33. Quamme GA. Control of magnesium transport in the thick ascending limb. Am J Physiol 1989;256:F197-F210
34. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT.Hypomagnesemia in patientswith type 2 diabetes. Clin J Am Soc Nephrol 2007;2:366-373
35. Ryzen E, Servis KL, DeRusso P, Kershaw A, Stephen T, Rude RK. Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency. J Am Coll Nutr 1989;8:580-587
36. Elin RJ. Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol 1994;102:616-622 (Pubitemid 24337555)